Granules India Limited, a pharmaceutical company, has completed the U.S. Food and Drug Administration’s (USFDA) Pre-Approval Inspection (PAI) and GMP audit for their facility (Unit IV) at Visakhapatnam in Andhra Pradesh.
“The Vizag facility was inspected by a USFDA team from June 26 to 30, while the Jeedimetla facility completed the process from June 19 to 23.
The successful completion of the inspection by the FDA reflects our commitment to quality and compliance,” Krishna Prasad Chigurupati, Chairman and Managing Director of Granules India, said.
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon: